Novo Nordisk Announces Winner of Race with Insulin® "Pit Crew" Sweepstakes

  Novo Nordisk Announces Winner of Race with Insulin® "Pit Crew" Sweepstakes

PR Newswire

PLAINSBORO, N.J., Oct. 23, 2013

PLAINSBORO, N.J., Oct. 23, 2013 /PRNewswire/ --Novo Nordisk, a world leader
in diabetes care announced that Richard A. from Fresno, California is the
winner of the Race with Insulin^® "pit crew" sweepstakes. The sweepstakes
launched in April and asked people to support IZOD IndyCar Series driver
Charlie Kimball by encouraging their friends and family to join the Race with
Insulin^® crew.

The Race with Insulin^® "pit crew" sweepstakes sought to recognize those who
provide support, including the family, friends, co-workers and health care
professionals who assist patients in managing their diabetes.

"I could not compete without my crew who help me manage my car and my
diabetes," said Kimball. "This contest puts the spotlight on everyone who
supports people with diabetes, including family and friends who are so
critical when it comes to day-to-day diabetes management."

As the first licensed driver with diabetes to win a Series race, Kimball
strategized with his doctor and his team to create some innovative solutions
for keeping him safe and healthy on the track. Along with diet, exercise and
the support of his crew, Charlie uses a prefilled insulin pen and a continuous
glucose monitor to help manage his blood sugar before and during races, so
that while he's in the car, he can focus on driving.

Since the sweepstakes launched, more than 3,160 entries have been received.
Grand prize winner, Richard A. andtwo friendsjoined Kimball's crew for a
trip to Southern California for the IndyCar World Championship on October 19,

As part of the sweepstakes, ten first prize winnersalso received an
autographed Charlie Kimball Official die cast of Kimball's car. The winners
were selected in a random drawing in September.

For more information about Charlie, visit You can
also follow Charlie on Twitter at @racewithinsulin.

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global health care company with 90
years of innovation and leadership in diabetes care. The company also has
leading positions within hemophilia care, growth hormone therapy and hormone
replacement therapy. For more information, visit or follow
our news in the US on Twitter: @NovoNordiskUS.

About Diabetes
In the United States, 25.8 million people have diabetes^1, a condition in
which the body does not produce enough or properly use insulin, the hormone
needed to convert sugar, starches and other food into energy needed for daily


Race with Insulin^® is a registered trademark of Novo Nordisk A/S.

© 2013 Novo Nordisk All rights reserved. 1013-00018351-1 October

^1 2011 National Diabetes Fact Sheet. Centers for Disease Control. Accessed October

SOURCE Novo Nordisk

Contact: Sarah Spielvogel, Novo Nordisk, 609-786-4278,
Press spacebar to pause and continue. Press esc to stop.